Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
2002 3
2003 4
2004 1
2005 2
2006 4
2007 14
2008 5
2009 6
2010 6
2011 7
2012 4
2013 10
2014 7
2015 4
2016 7
2017 8
2018 10
2019 11
2020 8
2021 10
2022 5
2023 9
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

131 results

Results by year

Filters applied: . Clear all
Page 1
Trastuzumab deruxtecan in metastatic breast cancer with variable HER2 expression: the phase 2 DAISY trial.
Mosele F, Deluche E, Lusque A, Le Bescond L, Filleron T, Pradat Y, Ducoulombier A, Pistilli B, Bachelot T, Viret F, Levy C, Signolle N, Alfaro A, Tran DTN, Garberis IJ, Talbot H, Christodoulidis S, Vakalopoulou M, Droin N, Stourm A, Kobayashi M, Kakegawa T, Lacroix L, Saulnier P, Job B, Deloger M, Jimenez M, Mahier C, Baris V, Laplante P, Kannouche P, Marty V, Lacroix-Triki M, Diéras V, André F. Mosele F, et al. Among authors: saulnier p. Nat Med. 2023 Aug;29(8):2110-2120. doi: 10.1038/s41591-023-02478-2. Epub 2023 Jul 24. Nat Med. 2023. PMID: 37488289 Free PMC article. Clinical Trial.
Carboplatin plus etoposide versus topotecan as second-line treatment for patients with sensitive relapsed small-cell lung cancer: an open-label, multicentre, randomised, phase 3 trial.
Baize N, Monnet I, Greillier L, Geier M, Lena H, Janicot H, Vergnenegre A, Crequit J, Lamy R, Auliac JB, Letreut J, Le Caer H, Gervais R, Dansin E, Madroszyk A, Renault PA, Le Garff G, Falchero L, Berard H, Schott R, Saulnier P, Chouaid C; Groupe Français de Pneumo-Cancérologie 01–13 investigators. Baize N, et al. Among authors: saulnier p. Lancet Oncol. 2020 Sep;21(9):1224-1233. doi: 10.1016/S1470-2045(20)30461-7. Lancet Oncol. 2020. PMID: 32888454 Clinical Trial.
Specificity of pharmacokinetic modeling of nanomedicines.
Lebreton V, Legeay S, Saulnier P, Lagarce F. Lebreton V, et al. Among authors: saulnier p. Drug Discov Today. 2021 Oct;26(10):2259-2268. doi: 10.1016/j.drudis.2021.04.017. Epub 2021 Apr 20. Drug Discov Today. 2021. PMID: 33892140 Review.
Lipid-based nanoformulations for peptide delivery.
Matougui N, Boge L, Groo AC, Umerska A, Ringstad L, Bysell H, Saulnier P. Matougui N, et al. Among authors: saulnier p. Int J Pharm. 2016 Apr 11;502(1-2):80-97. doi: 10.1016/j.ijpharm.2016.02.019. Epub 2016 Feb 17. Int J Pharm. 2016. PMID: 26899976 Free article. Review.
NMR diffusometry: A new perspective for nanomedicine exploration.
Franconi F, Lemaire L, Gimel JC, Bonnet S, Saulnier P. Franconi F, et al. Among authors: saulnier p. J Control Release. 2021 Sep 10;337:155-167. doi: 10.1016/j.jconrel.2021.07.025. Epub 2021 Jul 16. J Control Release. 2021. PMID: 34280413 Review.
Human virome profiling identified CMV as the major viral driver of a high accumulation of senescent CD8+ T cells in patients with advanced NSCLC.
Naigeon M, Roulleaux Dugage M, Danlos FX, Boselli L, Jouniaux JM, de Oliveira C, Ferrara R, Duchemann B, Berthot C, Girard L, Flippot R, Albiges L, Farhane S, Saulnier P, Lacroix L, Griscelli F, Roman G, Hulett T, Marabelle A, Cassard L, Besse B, Chaput N. Naigeon M, et al. Among authors: saulnier p. Sci Adv. 2023 Nov 10;9(45):eadh0708. doi: 10.1126/sciadv.adh0708. Epub 2023 Nov 8. Sci Adv. 2023. PMID: 37939189 Free PMC article.
Physico-chemical stability of colloidal lipid particles.
Heurtault B, Saulnier P, Pech B, Proust JE, Benoit JP. Heurtault B, et al. Among authors: saulnier p. Biomaterials. 2003 Oct;24(23):4283-300. doi: 10.1016/s0142-9612(03)00331-4. Biomaterials. 2003. PMID: 12853260 Review.
131 results